Please use this identifier to cite or link to this item:
https://biore.bio.bg.ac.rs/handle/123456789/2416| Title: | Transcription factor NF-Y inhibits cell growth and decreases SOX2 expression in human embryonal carcinoma cell line NT2/D1 | Authors: | Mojsin, M. Topalovic, V. Marjanovic Vicentic, J. Stevanović, Milena |
Keywords: | cell growth;NF-Y transcription factor;NT2/D1 cell line;p53;SOX2 | Issue Date: | Feb-2015 | Journal: | Biochemistry (Moscow) | Abstract: | © 2015 Pleiades Publishing, Ltd. Transcription factor NF-Y belongs to the embryonic stem cell transcription factor circuitry due to its role in the regulation of cell proliferation. We investigated the role of NF-Y in pluripotency maintenance using NT2/D1 cells as one of the best-characterized human embryonal carcinoma cell line. We investigated the efficiency of protein transduction and analyzed the effects of forced expression of short isoform of NF-Y A-subunit (NF-YAs) on NT2/D1 cell growth and expression of SOX2. We found that protein transduction is an efficient method for NF-Y overexpression in NT2/D1 cells. Next, we analyzed the effect of NF-YAs overexpression on NT2/D1 cell viability and detected significant reduction in cell growth. The negative effect of NF-YAs overexpression on NT2/D1 cell pluripotency maintenance was confirmed by the decrease in the level of the pluripotency marker SOX2. Finally, we checked the p53 status and determined that the NF-Y-induced inhibition of NT2/D1 cell growth is p53-independent. |
URI: | https://biore.bio.bg.ac.rs/handle/123456789/2416 | ISSN: | 0006-2979 | DOI: | 10.1134/S0006297915020066 |
| Appears in Collections: | Journal Article |
Files in This Item:
| File | Description | Size | Format | Existing users please |
|---|---|---|---|---|
| mojsin2015Biochemistry(Mosc).pdf | 142.72 kB | Adobe PDF | Request a copy |
SCOPUSTM
Citations
8
checked on Dec 20, 2025
Page view(s)
47
checked on Nov 10, 2026
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.